Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Southern University of Science and Technology
Headquarters: Shenzhen, China
Website: http://sustc.edu.cn/en/
Year Founded: 2007
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Oct 9, 2023
Distillery Therapeutics
Multivalent antibiotics for Gram-positive bacterial infections
BioCentury | Mar 16, 2023
Data Byte
Translational spotlight on variant-proofing tech for COVID and beyond
Host targets and antiviral strategies with efficacy across multiple viruses in BioCentury’s Distillery
BioCentury | Oct 28, 2020
Distillery Therapeutics
LIMS1 identified as NSCLC target
DISEASE CATEGORY: Cancer
INDICATION: Non-small cell lung cancer (NSCLC) Targeting the focal adhesion protein LIMS1 could treat NSCLC. In patients with lung adenocarcinoma, LIMS1 expression was
INDICATION: Non-small cell lung cancer (NSCLC) Targeting the focal adhesion protein LIMS1 could treat NSCLC. In patients with lung adenocarcinoma, LIMS1 expression was
BioCentury | Mar 28, 2020
Translation in Brief
17 FDA-approved drugs show activity against SARS-CoV-2; two groups seek COVID-19 patient-derived mAbs; plus NYU, Scholar Rock and LIfT-King's College
BioCentury's roundup of preclinical news
BioCentury | Mar 19, 2019
Regulation
Talk less, do more: Germline gene editing needs real plans, not just moratoria
Editor's Commentary: Why the international community should fund, coordinate labs for safe use of germline gene editing
Items per page:
1 - 10 of 15